Virus antibody responses in patients with myelin oligodendrocyte glycoprotein antibody-associated disease and multiple sclerosis
Our findings suggest that development of MOGAD is neither associated with SARS-CoV-2, HHV6, CMV nor JCV alone. Furthermore, results presented indicate that EBV serology is different in MOGAD patients compared to RRMS, confirming a role of EBV in the development of MS and suggesting that the etiology of MOGAD is different from MS.
Authors
- E Ciplys
- NH Trier
- G Houen
- JLgnh Frederiksen
- D Žiogienė
- R Slibinskas
Institutions
- Vilnius University (LT)
- University of Southern Denmark (DK)
- Glostrup Hospital (DK)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1016/j.msard.2026.107014
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00